The Massachusetts Life Sciences Center, the agency charged with implementing the Commonwealth’s 10-year, $1-billion investment initiative in the local life sciences industry, said its board of directors awarded an $8 million capital grant to support the Center for Personalized Cancer Therapy on the University of Massachusetts Boston campus.
The center is a joint program of UMass Boston and the Dana-Farber/Harvard Cancer Center. The goal of the Center for Personalized Cancer Therapy is to translate laboratory-based discoveries into clinical practice that will identify and implement individualized therapeutic choices to successfully eliminate human tumor progression and recurrence. The Massachusetts Life Sciences Center awarded the center a $2 million grant in 2011. The plan is for the Center for Personalized Cancer Therapy to move into its permanent home at UMass Boston’s Integrated Sciences Complex in the fall.
“Medicine is moving in the direction of customized treatment, and this investment keeps pace in our efforts to improve patient outcomes and create jobs,” Governor Deval Patrick said in a statement.
Patrick has made promoting the local life sciences industry a priority of his administration.
In a separate statement, Massachusetts Life Sciences Center president and chief executive Susan Windham-Bannister said, “This project will address the long-standing racial, ethnic and economic disparities that exist in cancer care as well as improve the quality of care for all cancer patients.”